Jubilant Pharmova Limited (BOM:530019)
India · Delayed Price · Currency is INR 981.60
-10.40 (-1.05%)
At close: Jun 16, 2026
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 155.48 billion as of June 16, 2026. Its market cap has decreased by -13.33% in one year.
Market Cap
155.48B
Enterprise Value
178.98B
Revenue
82.80B
Ranking
n/a
PE Ratio
39.14
Stock Price
981.60
Market Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 155.48B, an increase of 38,127.29%. That is a compound annual growth rate of 25.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 155.48B | -8.67% |
| Dec 31, 2025 | 170.24B | -2.67% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 363.09B |
| GlaxoSmithKline Pharmaceuticals | 359.26B |
| Rubicon Research | 213.43B |
| AstraZeneca Pharma India | 206.10B |
| Granules India | 189.84B |
| Caplin Point Laboratories | 183.29B |
| Viyash Scientific | 109.09B |
| CORONA Remedies | 105.70B |